{"id":"https://openalex.org/W2940915820","doi":null,"title":"ESR1 Mutations Not Implicated in Fulvestrant Resistance","display_name":"ESR1 Mutations Not Implicated in Fulvestrant Resistance","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-01","ids":{"openalex":"https://openalex.org/W2940915820","mag":"2940915820"},"language":"en","primary_location":{"id":"mag:2940915820","doi":null,"is_oa":false,"landing_page_url":"https://www.oncotherapynetwork.com/breast-cancer-targets/esr1-mutations-not-implicated-fulvestrant-resistance","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2940915820"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028956730","display_name":"Bryant Furlow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bryant Furlow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5028956730"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9204000234603882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9204000234603882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.04470000043511391,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.02070000022649765,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.9959999918937683},{"id":"https://openalex.org/keywords/fulvestrant-resistance","display_name":"fulvestrant resistance","score":0.9179999828338623},{"id":"https://openalex.org/keywords/aromatase-inhibitor-resistance","display_name":"aromatase inhibitor resistance","score":0.9020000100135803},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.8410000205039978}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.7908141613006592},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.37867897748947144},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3137950599193573},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17388534545898438},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.13675647974014282},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.09201332926750183}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2940915820","doi":null,"is_oa":false,"landing_page_url":"https://www.oncotherapynetwork.com/breast-cancer-targets/esr1-mutations-not-implicated-fulvestrant-resistance","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2374277491","https://openalex.org/W4388837170","https://openalex.org/W2958196506","https://openalex.org/W2565707423","https://openalex.org/W4221057282","https://openalex.org/W2766013939","https://openalex.org/W3193378962","https://openalex.org/W2944002852","https://openalex.org/W2415372857","https://openalex.org/W2788973992"],"abstract_inverted_index":{"ESR1":[0],"mutations,":[1],"which":[2],"are":[3,16],"believed":[4],"to":[5,22],"convey":[6],"aromatase":[7],"inhibitors":[8],"(AIs)":[9],"resistance":[10,21],"in":[11],"ER-positive,":[12],"metastatic":[13],"breast":[14],"cancer,":[15],"not":[17],"associated":[18],"with":[19],"tumor":[20],"fulvestrant.":[23]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2940915820","counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-05-03T00:00:00"}
